[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB0409596D0 - Novel herpes simplex viruses and uses thereof - Google Patents

Novel herpes simplex viruses and uses thereof

Info

Publication number
GB0409596D0
GB0409596D0 GBGB0409596.4A GB0409596A GB0409596D0 GB 0409596 D0 GB0409596 D0 GB 0409596D0 GB 0409596 A GB0409596 A GB 0409596A GB 0409596 D0 GB0409596 D0 GB 0409596D0
Authority
GB
United Kingdom
Prior art keywords
herpes simplex
simplex viruses
novel herpes
novel
viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0409596.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Glasgow
Crusade Laboratories Ltd
Original Assignee
University of Glasgow
Crusade Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Glasgow, Crusade Laboratories Ltd filed Critical University of Glasgow
Priority to GBGB0409596.4A priority Critical patent/GB0409596D0/en
Publication of GB0409596D0 publication Critical patent/GB0409596D0/en
Priority to PCT/GB2005/001654 priority patent/WO2005105833A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/763—Herpes virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16632—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16641—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
    • C12N2840/206—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES having multiple IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0409596.4A 2004-04-29 2004-04-29 Novel herpes simplex viruses and uses thereof Ceased GB0409596D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0409596.4A GB0409596D0 (en) 2004-04-29 2004-04-29 Novel herpes simplex viruses and uses thereof
PCT/GB2005/001654 WO2005105833A2 (en) 2004-04-29 2005-04-29 Novel herpes simplex viruses and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0409596.4A GB0409596D0 (en) 2004-04-29 2004-04-29 Novel herpes simplex viruses and uses thereof

Publications (1)

Publication Number Publication Date
GB0409596D0 true GB0409596D0 (en) 2004-06-02

Family

ID=32408259

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0409596.4A Ceased GB0409596D0 (en) 2004-04-29 2004-04-29 Novel herpes simplex viruses and uses thereof

Country Status (2)

Country Link
GB (1) GB0409596D0 (en)
WO (1) WO2005105833A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110117577B (en) * 2018-02-05 2023-10-24 中国科学院武汉物理与数学研究所 Low-toxicity herpes simplex virus system and construction method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045443A1 (en) * 1997-04-10 1998-10-15 Human Gene Therapy Research Institute Radioisotope concentrator methods and compositions
ATE466078T1 (en) * 2000-11-29 2010-05-15 Univ Rochester HELPER VIRUS-FREE HERPES VIRUS AMPLIFICATE PARTICLES AND USES THEREOF
GB0326798D0 (en) * 2003-11-17 2003-12-24 Crusade Lab Ltd Methods for generating mutant virus

Also Published As

Publication number Publication date
WO2005105833A2 (en) 2005-11-10
WO2005105833A3 (en) 2006-02-02

Similar Documents

Publication Publication Date Title
IL179545A0 (en) Viral and viral associated mirnas and uses thereof
EP1802588A4 (en) Substituted amino-pyrimidones and uses thereof
HK1214812A1 (en) Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors -6- pde4
EP1887067A4 (en) Phosphor and use thereof
IL181670A0 (en) Substituted phenylaminothiazoles and use thereof
ZA200800256B (en) Antiviral compounds and methods
PL372937A1 (en) Viral antigens
EP1781336A4 (en) Novel hydrogels and uses thereof
GB0206359D0 (en) Viral antigens
IL179497A0 (en) Carboranylporphyrins and uses thereof
EP1781311A4 (en) Growth-hormone secretagogues
EP1723238A4 (en) Modified oncolytic viruses
EP1824467A4 (en) Apogossypolone and the uses thereof
IL180365A0 (en) Carboranylporphyrins and uses thereof
GB0416487D0 (en) Modified virus
GB0406389D0 (en) Recombinant herpes simplex virus and uses therefor
PL2215908T3 (en) 2-Alkyl-cycloalk(en)yl-carboxamides and their use as fungizides
IL177759A0 (en) Cospeptin, cosmedin and their uses
EP1725399A4 (en) Adhesive sheets and methods for their use
GB2418628B (en) Improved laminates and the manufacture thereof
GB0409596D0 (en) Novel herpes simplex viruses and uses thereof
GB0408103D0 (en) Novel herpes simplex viruses
GB0405657D0 (en) Recombinant herpes simplex virus and uses therefor
GB0408424D0 (en) Viral assay
GB0517617D0 (en) Treatment using herpes simplex virus

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)